Dopamine Receptor Agonists for Protection and Repair in Parkinson's Disease

E-ISSN： 1873-4294|8|12|1089-1099

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.8, Iss.12, 2008-08, pp. : 1089-1099

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Are Dopamine Receptor Agonists Neuroprotective in Parkinson's Disease?

By Le W-D. Jankovic J.

Drugs & Aging, Vol. 18, Iss. 6, 2001-06 ,pp. : 389-396

Adis International

Access to resources Recommend Favorite

Dopamine agonists in Parkinson’s disease

By Tintner Ron Jankovic Joseph

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1803-1820

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacology of Dopamine Agonists in Parkinson's Disease

By Lange K.W.

Drugs & Aging, Vol. 13, Iss. 5, 1998-11 ,pp. : 381-389

Adis International

Access to resources Recommend Favorite

The safety of dopamine agonists in the treatment of Parkinson's disease

By Bonuccelli Ubaldo Ceravolo Roberto

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 111-127

Informa Healthcare

Access to resources Recommend Favorite

Dopamine D Receptor Agonists: The Way Forward for the Treatment of Parkinson's Disease?

By Vermeulen R.J. Drukarch B. Wolters E.C. Stoof J.C.

CNS Drugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 83-91

Adis International

Access to resources Recommend Favorite